FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware'

FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware'  Forbes US FDA allows 23andMe to sell test for 3 mutations of breast cancer gene  Reuters 23andMe can now tell you about your breast cancer risk  Business InsiderFull coverage

Read More ...
FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware' published March 07, 2018 at 12:11AM. Original Source Link : https://www.forbes.com/sites/arleneweintraub/2018/03/06/fda-clears-23andmes-dtc-breast-cancer-gene-test-but-buyer-beware/

loading...